Researchers showed that 1.34 mg of Fotivda provided decreased tumor size and may be more tolerable than an 0.89-mg dose among patients with renal cell carcinoma.
The Food and Drug Administration said it was taking the action because studies found that the dye, also known as erythrosine, ...
The WHO’s cancer agency’s designation for hairstylists does not extend to people who dye their hair. That remains “not ...
Thomas Cooper’s parents hoped the oxygen therapy he was receiving at a facility in Troy, Michigan, would help his sleep apnea ...
Red dye 3 has been banned in America, what comes next? - Robert F. Kennedy Jr. campaigned on a focus on artificial dyes and ...
19h
A federal appellate court has upheld the Drug Enforcement Administration’s denial of a Seattle doctor’s request to use ...
Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
22hOpinion
The F.D.A. is making its biggest move yet to end smoking. It needs to be careful not to give rise to another public health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback